BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16850103)

  • 1. Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region.
    Korshunov A; Cherekaev V; Bekyashev A; Sycheva R
    J Neurooncol; 2007 Jan; 81(2):131-7. PubMed ID: 16850103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
    Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques.
    Woo KS; Sung KS; Kim KU; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2008 Jan; 180(1):56-9. PubMed ID: 18068535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
    Ozaki S; Nishizaki T; Ito H; Sasaki K
    J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features.
    Tabernero MD; Espinosa AB; Maíllo A; Sayagués JM; Alguero Mdel C; Lumbreras E; Díaz P; Gonçalves JM; Onzain I; Merino M; Morales F; Orfao A
    Am J Clin Pathol; 2005 May; 123(5):744-51. PubMed ID: 15981814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel chromosomal aberrations in a recurrent malignant meningioma.
    Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
    Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.
    Pfisterer WK; Coons SW; Aboul-Enein F; Hendricks WP; Scheck AC; Preul MC
    J Neurooncol; 2008 Mar; 87(1):43-50. PubMed ID: 18060363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
    Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
    Ketter R; Urbschat S; Henn W; Feiden W; Beerenwinkel N; Lengauer T; Steudel WI; Zang KD; Rahnenführer J
    Int J Cancer; 2007 Oct; 121(7):1473-80. PubMed ID: 17557299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
    Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
    Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence.
    Urbschat S; Rahnenführer J; Henn W; Feiden W; Wemmert S; Linsler S; Zang KD; Oertel J; Ketter R
    Int J Oncol; 2011 Dec; 39(6):1601-8. PubMed ID: 21922133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.